13.2. Analysis.
Comparison 13 Target of rapamycin inhibitors (TOR‐I) versus antimetabolites (AM): subgroup analyses, Outcome 2 Acute rejection (risk of bias for sequence generation and allocation concealment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.